Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 November 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 192 pages)

 

Export 2363 results:
Author Title Type [ Year(Asc)]
2019
M. Pufulete, Harris, J., Sterne, J. A. C., Johnson, T. W., Lasserson, D., Mumford, A., Doble, B., Wordsworth, S., Benedetto, U., Rogers, C. A., Loke, Y., Pithara, C., Redwood, S., and Reeves, B. C., “Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Stu”, BMJ Open, vol. 9, p. e029388, 2019.
M. E. Saine, Carbonari, D. M., Newcomb, C. W., Gallagher, A. M., Blak, B. T., Roy, J. A., Wood, J., Cardillo, S., Hennessy, S., Strom, B. L., and , “Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies”, Pharmacoepidemiol Drug Saf, 2019.
C. I. Bloom, Douglas, I., Olney, J., D'Ancona, G., Smeeth, L., and Quint, J. K., “Cost saving of switching to equivalent inhalers and its effect on health outcomes”, Thorax, 2019.
S. V. Ramagopalan, Samnaliev, M., Weir, S., Sammon, C. J., Carroll, R., and Alikhan, R., “Costs of gastrointestinal bleeding events in atrial fibrillation: a UK Clinical Practice Research Datalink study”, Future Cardiol, 2019.
M. Touya, Lamy, F. X., Tanasescu, A., Saragoussi, D., Francois, C., Wade, A. G., Llorca, P. M., Lancon, C., and Falissard, B., “Creation and validation of a linear index to measure the health state of patients with depression in automated healthcare databases”, J Mark Access Health Policy, vol. 7, p. 1674115, 2019.
A. Wolf, Dedman, D., Campbell, J., Booth, H., Lunn, D., Chapman, J., and Myles, P., “Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum”, Int J Epidemiol, 2019.
A. Douros, Dell'Aniello, S., Dehghan, G., Boivin, J. F., and Renoux, C., “Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study”, Neurology, vol. 93, pp. e1010-e1020, 2019.
C. S. Arhi, Markar, S., Burns, E. M., Bouras, G., Bottle, A., Hanna, G., Aylin, P., Ziprin, P., and Darzi, A., “Delays in referral from primary care are associated with a worse survival in patients with esophagogastric cancer”, Dis Esophagus, 2019.
S. Hawley, Edwards, C. J., Arden, N. K., Delmestri, A., Cooper, C., Judge, A., and Prieto-Alhambra, D., “Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records”, Semin Arthritis Rheum, 2019.
H. Bricout, Torcel-Pagnon, L., Lecomte, C., Almas, M. F., Matthews, I., Lu, X., Wheelock, A., and Sevdalis, N., “Determinants of shingles vaccine acceptance in the United Kingdom”, PLoS One, vol. 14, p. e0220230, 2019.
S. Harmala, O'Brien, A., Parisinos, C. A., Direk, K., Shallcross, L., and Hayward, A., “Development and validation of a prediction model to estimate the risk of liver cirrhosis in primary care patients with abnormal liver blood test results: protocol for an electronic health record study in Clinical Practice Research Datalink”, Diagn Progn Res, vol. 3, p. 10, 2019.
N. Conrad, Judge, A., Canoy, D., Tran, J., O'Donnell, J., Nazarzadeh, M., Salimi-Khorshidi, G., Hobbs, F. D. R., Cleland, J. G., McMurray, J. J. V., and Rahimi, K., “Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients”, PLoS Med, vol. 16, p. e1002805, 2019.
D. Stolz, Kostikas, K., Loefroth, E., Fogel, R., Gutzwiller, F. S., Conti, V., Cao, H., and Clemens, A., “Differences in COPD exacerbation risk between women and men: analysis from the UK Clinical Practice Research Datalink data”, Chest, 2019.
A. Douros, Rouette, J., Yin, H., Yu, O. H. Y., Filion, K. B., and Azoulay, L., “Dipeptidyl Peptidase-4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes”, Diabetes Care, 2019.
S. V. Ramagopalan, Graham, S., Carroll, R., Raluy-Callado, M., Nordstrom, B. L., Donaldson, R., Colby, C., Mehmud, F., and Alikhan, R., “Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin”, J Comp Eff Res, 2019.
G. Nakafero, Grainge, M., Valdes, A., Townsend, N., Mallen, C., Zhang, W., Doherty, M., Mamas, M. A., and Abhishek, A., “Do beta-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink”, BMJ Open, vol. 9, p. e032050, 2019.
Y. Li, Sperrin, M., Belmonte, M., Pate, A., Ashcroft, D. M., and van Staa, T. P., “Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?”, Sci Rep, vol. 9, p. 11222, 2019.
I. Karp, Sivaswamy, A., and Booth, C., “Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?”, Pharmacoepidemiol Drug Saf, 2019.
Y. Tao and Fu, H., “Doubly robust estimation of the weighted average treatment effect for a target population”, Stat Med, vol. 38, pp. 315-325, 2019.
A. Jaggi, Nazir, J., Fatoye, F., Siddiqui, E., Choudhury, N., Argoubi, R., Ali, M., de Ridder, D., and Drake, M. J., “Drug utilization patterns and healthcare resource use and costs in patients with neurogenic bladder in the United Kingdom: A retrospective primary care database study”, Neurourol Urodyn, 2019.
M. L. Henry, Abdul-Sultan, A., Walker, A. J., West, J., and Humes, D. J., “Duration and Magnitude of Postoperative Risk of Venous Thromboembolism after Cholecystectomy: A Population-Based Cohort Study”, Dig Surg, pp. 1-7, 2019.
O. M. Moussa, Ardissino, M., Kulatilake, P., Faraj, A., Muttoni, E., Darzi, A., Ziprin, P., Scholtz, S., and Purkayastha, S., “Effect of body mass index on depression in a UK cohort of 363 037 obese patients: A longitudinal analysis of transition”, Clin Obes, p. e12305, 2019.
G. S. Matharu, Mouchti, S., Twigg, S., Delmestri, A., Murray, D. W., Judge, A., and Pandit, H. G., “The effect of smoking on outcomes following primary total hip and knee arthroplasty: a population-based cohort study of 117,024 patients”, Acta Orthop, pp. 1-9, 2019.
M. J. Cook, Sorial, A. K., Lunt, M., Board, T. N., and O'Neill, T. W., “Effect of timing and duration of statin exposure on risk of hip or knee revision arthroplasty: a population-based cohort study”, J Rheumatol, 2019.
M. C. Gulliford, Prevost, A. T., Charlton, J., Juszczyk, D., Soames, J., McDermott, L., Sultana, K., Wright, M., Fox, R., Hay, A. D., Little, P., Moore, M. V., Yardley, L., and Ashworth, M., “Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial”, Bmj, vol. 364, p. l236, 2019.
K. Marinier, Macouillard, P., de Champvallins, M., Deltour, N., Poulter, N., and Mancia, G., “Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, 2019.
K. Mattishent, Richardson, K., Dhatariya, K., Savva, G. M., Fox, C., and Loke, Y. K., “The effects of hypoglycemia and dementia on cardiovascular events, falls and fractures and all-cause mortality in older people - a retrospective cohort study”, Diabetes Obes Metab, 2019.
M. C. Gulliford, Juszczyk, D., Prevost, A. T., Soames, J., McDermott, L., Sultana, K., Wright, M., Fox, R., Hay, A. D., Little, P., Moore, M., Yardley, L., Ashworth, M., and Charlton, J., “Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study”, Health Technol Assess, vol. 23, pp. 1-70, 2019.
E. Herrett, Gadd, S., Jackson, R., Bhaskaran, K., Williamson, E., Van Staa, T., Sofat, R., Timmis, A., and Smeeth, L., “Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study”, Lancet, 2019.
H. Whittaker, Connell, O., Campbell, J., Elbehairy, A. F., Hopkinson, N. S., and Quint, J. K., “Eligibility for Lung Volume Reduction Surgery in Chronic Obstructive Pulmonary Disease patients identified in a UK primary care setting”, Chest, 2019.
R. Ferguson, Culliford, D., Prieto-Alhambra, D., Pinedo-Villanueva, R., Delmestri, A., Arden, N., and Bowen, C., “Encounters for foot and ankle pain in UK primary care: a population-based cohort study of CPRD data”, Br J Gen Pract, vol. 69, pp. e422-e429, 2019.
L. Horne, Ashfaq, A., MacLachlan, S., Sinsakul, M., Qin, L., LoCasale, R., and Wetmore, J. B., “Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England”, BMC Nephrol, vol. 20, p. 85, 2019.
S. Wood, Marchant, A., Allsopp, M., Wilkinson, K., Bethel, J., Jones, H., and John, A., “Epidemiology of eating disorders in primary care in children and young people: a Clinical Practice Research Datalink study in England”, BMJ Open, vol. 9, p. e026691, 2019.
M. Eberg, Platt, R. W., Reynier, P., and Filion, K. B., “Estimation of high-dimensional propensity scores with multiple exposure levels”, Pharmacoepidemiol Drug Saf, 2019.
K. Hedenmalm, Blake, K., Donegan, K., Macia, M. A., Gil, M., Williams, J., Montero, D., Candore, G., Morales, D., Kurz, X., and Arlett, P., “A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children”, Pharmacoepidemiol Drug Saf, 2019.
C. Marley, Y. Hahi, E., Ferreira, G., Woods, L., and A. Villaescusa, R., “Evaluation of a risk score to predict future Clostridium difficile disease using UK primary care and hospital data in Clinical Practice Research Datalink”, Hum Vaccin Immunother, pp. 1-7, 2019.
C. F. Vogelmeier, Kostikas, K., Fang, J., Tian, H., Jones, B., Morgan, C. L., Fogel, R., Gutzwiller, F. S., and Cao, H., “Evaluation of exacerbations and blood eosinophils in UK and US COPD populations”, Respir Res, vol. 20, p. 178, 2019.
L. A. Scott, Berni, T. R., Berni, E. R., De Vries, J., and Currie, C. J., “Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United Kingdom”, Expert Rev Clin Immunol, vol. 15, pp. 889-896, 2019.
S. Bellass, Taylor, J., Han, L., Prady, S. L., Shiers, D., Jacobs, R., Holt, R. I. G., Radford, J., Gilbody, S., Hewitt, C., Doran, T., Alderson, S. L., and Siddiqi, N., “Exploring Severe Mental Illness and Diabetes: Protocol for a Longitudinal, Observational, and Qualitative Mixed Methods Study”, JMIR Res Protoc, vol. 8, p. 13407, 2019.
R. M. Joseph, van Staa, T. P., Lunt, M., Abrahamowicz, M., and Dixon, W. G., “Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data”, Pharmacoepidemiol Drug Saf, vol. 28, pp. 179-186, 2019.
M. H. Secrest, Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., Doyle, C. M., Dell'Aniello, S., and Filion, K. B., “Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research”, Pharmacoepidemiol Drug Saf, 2019.
A. Bottle, Kim, D., Hayhoe, B., Majeed, A., Aylin, P., Clegg, A., and Cowie, M. R., “Frailty and comorbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England”, Age Ageing, 2019.
P. Liu, McMenamin, U. C., Spence, A. D., Johnston, B. T., Coleman, H. G., and Cardwell, C. R., “Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study”, BMC Cancer, vol. 19, p. 1017, 2019.
M. D. Danese, Halperin, M., Duryea, J., and Duryea, R., “The Generalized Data Model for clinical research”, BMC Med Inform Decis Mak, vol. 19, p. 117, 2019.
D. F. Carr, Francis, B., Jorgensen, A. L., Zhang, E., Chinoy, H., Heckbert, S. R., Bis, J. C., Brody, J. A., Floyd, J., Psaty, B. M., Molokhia, M., Lapeyre-Mestre, M., Conforti, A., Alfirevic, A., Van Staa, T., and Pirmohamed, M., “Genome-wide association study of statin-induced myopathy in patients recruited using the UK clinical practice research datalink”, Clin Pharmacol Ther, 2019.
R. Smith, Han, L., Ali, S., Prady, S. L., Taylor, J., Hughes, T., Ajjan, R. A., Siddiqi, N., and Doran, T., “Glucose, cholesterol and blood pressure in type II diabetes: A longitudinal observational study comparing patients with and without severe mental illness”, J Psychiatr Ment Health Nurs, 2019.
P. H. Wilding J, Rigney, U., Blak, B. T., Nolan, S. T., Fenici, P., and Medina, J., “Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus”, Diabetes Res Clin Pract, p. 107791, 2019.
A. G. Stack, Johnson, M. E., Blak, B., Klein, A., Carpenter, L., Morlock, R., Maguire, A. R., and Parsons, V. L., “Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study”, BMJ Open, vol. 9, p. e031550, 2019.
S. Alageel and Gulliford, M. C., “Health checks and cardiovascular risk factor values over six years' follow-up: Matched cohort study using electronic health records in England”, PLoS Med, vol. 16, p. e1002863, 2019.
L. Harris, Graham, S., MacLachlan, S., Exuzides, A., and Jacob, S., “Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England”, J Med Econ, pp. 1-7, 2019.
[Page last reviewed 4 November 2019]